Stockreport

Nuvation Bio to Present at the Cantor Global Healthcare Conference

Nuvation Bio Inc. Class A  (NUVB) 
PDF NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncol [Read more]